1. Home
  2. ANGI vs MNPR Comparison

ANGI vs MNPR Comparison

Compare ANGI & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$7.39

Market Cap

376.6M

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$60.36

Market Cap

372.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
MNPR
Founded
1995
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
376.6M
372.9M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
ANGI
MNPR
Price
$7.39
$60.36
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$17.00
$101.42
AVG Volume (30 Days)
1.1M
144.9K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
1242.86
N/A
EPS
0.94
N/A
Revenue
$736,386,000.00
N/A
Revenue This Year
$3.25
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
$7.83
N/A
Revenue Growth
47.60
N/A
52 Week Low
$7.36
$26.06
52 Week High
$19.42
$105.00

Technical Indicators

Market Signals
Indicator
ANGI
MNPR
Relative Strength Index (RSI) 31.47 54.42
Support Level N/A $56.15
Resistance Level $9.42 $61.30
Average True Range (ATR) 0.45 3.33
MACD 0.06 0.94
Stochastic Oscillator 2.61 86.28

Price Performance

Historical Comparison
ANGI
MNPR

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: